Missing/wrong data?
Log in to edit
Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study
scientific article
Author/s
author: Andrew K Godwin, R Katherine Alpaugh, Anil K. Sood
Work details
Publication date
June 16, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.